MAPRE2 Protein (Transcript Variant 3) (Myc-DYKDDDDK Tag)

Produktnummer ABIN2725485

Dieses Recombinant MAPRE2-Protein wird in HEK-293 Cells produziert.

Kurzübersicht für MAPRE2 Protein (Transcript Variant 3) (Myc-DYKDDDDK Tag) (ABIN2725485)

Target: MAPRE2 (Microtubule-Associated Protein, RP/EB Family, Member 2 (MAPRE2))

Protein-Typ: Recombinant

Spezies: Human

Quelle: HEK-293 Cells

Applikation: Antibody Production (AbP), Standard (STD)

Reinheit: > 80 % as determined by SDS-PAGE and Coomassie blue staining

Produktdetails

Proteineigenschaft: Transcript Variant 3

Aufreinigungstag / Konjugat: Dieses MAPRE2 Protein ist gelabelt mit Myc-DYKDDDDK Tag.

Produktmerkmale:

• Recombinant human MAPRE2 (transcript variant 3) protein expressed in HEK293 cells.
• Produced with end-sequenced ORF clone

Anwendungsinformationen

Applikationshinweise: Recombinant human proteins can be used for:
Native antigens for optimized antibody production
Positive controls in ELISA and other antibody assays

Kommentare:

The tag is located at the C-terminal.

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Konzentration: 50 μg/mL

Buffer: 25 mM Tris.HCl, pH 7.3, 100 mM glycine, 10 % glycerol.

Lagerung: -80 °C

Informationen zur Lagerung: Store at -80°C. Thaw on ice, aliquot to individual single-use tubes, and then re-freeze immediately. Only 2-3 freeze thaw cycles are recommended.

Antigendetails

Target: MAPRE2 (Microtubule-Associated Protein, RP/EB Family, Member 2 (MAPRE2))

Andere Bezeichnung: Mapre2

Hintergrund: The protein encoded by this gene shares significant homology to the adenomatous polyposis coli (APC) protein-binding EB1 gene family. This protein is a microtubule-associated protein that is necessary for spindle symmetry during mitosis. It is thought to play a role in the tumorigenesis of colorectal cancers and the proliferative control of normal cells. Alternative splicing of this gene results in multiple transcript variants.

Molekulargewicht: 35.6 kDa

NCBI Accession: NP_001137299